PURINE-MEDIATED AND NUCLEOTIDE-MEDIATED RELAXATION OF RABBIT THORACIC AORTA - COMMON AND DIFFERENT SITES OF ACTION

被引:18
作者
CHINELLATO, A
RAGAZZI, E
PANDOLFO, L
FROLDI, G
CAPARROTTA, L
FASSINA, G
机构
[1] Department of Pharmacology, University of Padova, Padova
关键词
D O I
10.1111/j.2042-7158.1994.tb03808.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The mechanisms of the relaxant effect of purines and pyrimidines in New Zealand rabbit isolated aorta were investigated at endothelial and smooth muscle cell levels. Endothelium-mediated relaxation by ATP was only partially inhibited by the P2-purinoceptor antagonist suramin (0.1 mm). The pyrimidine UTP produced vasodilation by acting at the endothelial level and relaxation was not antagonized by suramin (0.1 mM). This effect was not mediated by P2 purinoceptors, indicating that UTP, like ATP to a certain extent, produces relaxation via an endothelium nucleotide (N) pyrimidinoceptor. ATP, ADP, AMP, adenosine, 5'-N-ethylcarboxamidoadenosine (NECA) and inosine were all active as relaxants on smooth muscle. The NECA relaxant effect was not antagonized by P1-purinoceptor antagonists 3,7-dimethyl-1-propargylxanthine (50 muM) or 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine (5 muM), excluding a P1-mediated effect. P2-related activity was excluded because adenosine-mediated relaxation was not antagonized by suramin (0.1 mM). UTP was ineffective as a relaxant at smooth muscle level, thus excluding the presence of muscular nucleotide (N) pyrimidinoceptor and suggesting a P3 purinoceptor. The rank order of potency of this muscle purinoceptor was NECA > adenosine > ATP congruent-to ADP congruent-to AMP congruent-to inosine.
引用
收藏
页码:337 / 341
页数:5
相关论文
共 18 条
  • [1] ALLSUP DJ, 1990, MOL PHARMACOL, V38, P84
  • [2] ADENOSINE RECEPTOR-BINDING - STRUCTURE-ACTIVITY ANALYSIS GENERATES EXTREMELY POTENT XANTHINE ANTAGONISTS
    BRUNS, RF
    DALY, JW
    SNYDER, SH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (07): : 2077 - 2080
  • [3] BRUNS RF, 1986, MOL PHARMACOL, V29, P331
  • [4] IS THERE A BASIS FOR DISTINGUISHING 2 TYPES OF P2-PURINOCEPTOR
    BURNSTOCK, G
    KENNEDY, C
    [J]. GENERAL PHARMACOLOGY, 1985, 16 (05): : 433 - 440
  • [5] Burnstock G, 1978, CELL MEMBRANE RECEPT, P107
  • [6] CHINELLATO A, 1991, BLOOD VESSELS, V28, P358
  • [7] PHARMACOLOGICAL CHARACTERIZATION OF A NEW PURINERGIC RECEPTOR-SITE IN RABBIT AORTA
    CHINELLATO, A
    RAGAZZI, E
    PANDOLFO, L
    FROLDI, G
    CAPARROTTA, L
    FASSINA, G
    [J]. GENERAL PHARMACOLOGY, 1992, 23 (06): : 1067 - 1071
  • [8] PHARMACOLOGICAL CHARACTERIZATION OF ATP RECEPTORS MEDIATING VASODILATION ON ISOLATED RABBIT AORTA
    CHINELLATO, A
    RAGAZZI, E
    PANDOLFO, L
    FROLDI, G
    CAPARROTTA, L
    FASSINA, G
    [J]. GENERAL PHARMACOLOGY, 1992, 23 (05): : 861 - 865
  • [9] A NOVEL EXTRACELLULAR NUCLEOTIDE RECEPTOR COUPLED TO PHOSPHOINOSITIDASE-C IN PITUITARY-CELLS
    DAVIDSON, JS
    WAKEFIELD, IK
    SOHNIUS, U
    VANDERMERWE, PA
    MILLAR, RP
    [J]. ENDOCRINOLOGY, 1990, 126 (01) : 80 - 87
  • [10] STIMULATION OF PROSTACYCLIN RELEASE FROM AORTIC SMOOTH-MUSCLE CELLS BY PURINE AND PYRIMIDINE NUCLEOTIDES
    DEMOLLE, D
    LAGNEAU, C
    BOEYNAEMS, JM
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 155 (03) : 339 - 343